Kolon TissueGene, Inc.
KOE: 950160.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 29
- Headquarters
- Rockville, United States
- IPO year
- 2017
- Market cap
- ₩10.6T
- Website
- https://www.kolontissuegene.com
Loading 950160…
Loading profile data…Frequently asked questions about 950160
What does Kolon TissueGene, Inc. (950160.KQ) do?
Kolon TissueGene, Inc. is a biopharmaceutical company, which engages in the development of clinical-stage cell therapies for osteoarthritis. It offers TG-C, a platform technology that consists of a combination of allogeneic primary cells combined with genetically modified cells. The company was founded by Kwan H. Lee on June 9, 1999 and is headq...
Where does 950160.KQ trade?
Kolon TissueGene, Inc. (950160.KQ) trades on the KOSDAQ.
What sector is 950160.KQ in?
Kolon TissueGene, Inc. (950160.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Where is Kolon TissueGene, Inc. headquartered?
Kolon TissueGene, Inc. is headquartered in United States.
Does 950160.KQ pay a dividend?
Kolon TissueGene, Inc. (950160.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 950160.KQ go public?
Kolon TissueGene, Inc. (950160.KQ) completed its initial public offering in 2017.